ADAM17 and lung cancer: Notably, the predominant role of ADAM17 in mediating the pathological consequences of deregulated sIL-6R-driven IL-6 trans-signaling has recently been reported in Kras mutant LAC and cigarette smoke carcinogen (NNK)-induced lung cancer [29,131].